Skip to main content
Clinical Trials/IRCT201402113449N14
IRCT201402113449N14
Completed
Phase 2

Comparing effects of low dose heparin as intermittent SC injection and continuous IV infusion on the serum biomarkers of thrombosis in critically ill patients

Vice Chancellor for Research, Tehran University of Medical Sciences0 sites46 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Deep vein throbmosis.
Sponsor
Vice Chancellor for Research, Tehran University of Medical Sciences
Enrollment
46
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice Chancellor for Research, Tehran University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Critically ill patients with age between 18\-65 years old who will be admitted to ICU and have indication for deep vein thrombosis (DVT) prophylaxis
  • Exclusion criteria:
  • Patients who need DVT or pulmonary emboli treatment, have heparin contraindications, autoimmune diseases, history of acute myocardial infarction in last 21 days, and dialysis.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials